Caris Life Sciences, Inc.
CAI
Jodie situation report
Caris Life Sciences, Inc.'s move is being confirmed by its market group.
CAI accounts for 10.8% of the group's measured movement across 7.3 effective names. raw member direction is mixed; 6 of 10 SPY-adjusted paths align to the upside. Capital-flow agreement is 53%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
COGT, NTRA, VCYT moved materially before CAI. CAI crossed its material path threshold at 10:35 ET, 15 minutes after the first measured mover. MRNA, CRSP, SYRE followed.
5 of 10 members in Cancer Diagnostics are active. 0 of 8 disclosed connections are confirming.
- At least 7 of 10 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as MYGN begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.
Who this business touches
The relationships behind CAI
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ILMNIllumina, Inc.supplierMar 3, 2026 ▾
“Other companies offering testing in the precision oncology industry include Illumina, NeoGenomics, Myriad Genetics, Laboratory Corporation of America, Quest Diagnostics, and BostonGene.”
ABBVAbbVie Inc.partnerMay 8, 2026 ▾
“Our molecular profiling solutions and the data generated by our multi-omic technology platform also provide value to our biopharma partners, such as Moderna, AbbVie, Xencor, Merck KGaA and Genentech, through partnerships that aim to increase the probability o…”
Depended on by
BLLNBillionToOne, Inc.competitorMar 11, 2026 ▾
“In the oncology market, our main competitors for our therapy selection and response monitoring tests include Caris Life Sciences, Inc., Foundation Medicine, Inc., which was acquired by Roche Holdings, Inc., Guardant Health, Inc., NeoGenomics Laboratories, Inc…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 30 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CAI is currently a Follower in the organic co-movement group Cancer Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.